Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
VCVaccinex, Inc. logo

Vaccinex, Inc. (VCNX)

Other OTC · Currency in USD
$0.82 ▲ +0.12 (+17.14%)
At close: Oct 23, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.70
Open
$0.82
Day's Range
$0.70 – $0.82
52 Week Range
$0.31 – $1.50
Volume
2
Avg. Volume
1,069
Market Cap
$2.19M
Beta (5Y Monthly)
0.67
PE Ratio (TTM)
--
EPS (TTM)
-$1.97
Earnings Date
Nov 16, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Vaccinex, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
25
CEO
Maurice Zauderer

Vaccinex, Inc. is a biotechnology firm operating in the clinical stage, dedicated to identifying and developing specialized biological therapies. Its core mission is to address serious medical conditions and diseases that currently lack adequate treatment options. The company's therapeutic endeavors encompass a broad spectrum of illnesses, including various forms of cancer, neurodegenerative disorders, and autoimmune diseases.

Earnings

Next report: Mon, Nov 16, 2026
EPS estimate -$73.04 · Revenue est. $333.21K
DateEst.Actual
Apr 7, 2025–-$1.61
Nov 14, 2024–-$2.28
Aug 14, 2024–-$3.10
May 15, 2024–-$2.94
Apr 2, 2024-$48.28-$39.40Beat

Analyst view

Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on VCNX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.